Having strong governance does not eliminate hard questions in the boardroom. It simply helps ensure that when those questions ...

Researchers studied data from 27,885 patients taking GLP1 weight loss drugs such as semaglutide and tirzepatide.

Global markets face a precarious crossover of exigencies, as West Asia’s war, AI-led job losses and El Niño’s climate risks ...

New data from 2026 shows DAOs centralising, not decentralising. Corporate governance research explains why participation ...

Statistics show clear differences in the population's immune system according to sex: men are more susceptible to infections ...

Claude is Anthropic’s AI assistant for writing, coding, analysis, and enterprise workflows, with newer tools such as Claude ...

Scientists looked at a wide range of brain scans to determine how consciousness gets so trippy on mind-altering drugs.

A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...

The Q1 2026 update of the J.S. Held AI Disputes Monitor reveals a sharp rise in litigation, particularly in the insurance ...

The KRA approved only Sh774.8 million and rejected the balance of Sh1.06 billion, citing alleged undeclared sales based on ...

In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development. Skolnick has developed AI-based approaches to predict protein structure and function that ...

“We need a Manhattan Project for this,” one economist says. This story originally appeared in The Algorithm, our weekly ...